{"id":13079,"date":"2010-04-30T09:00:00","date_gmt":"2010-04-30T07:00:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/gsk-18-nel-1-trimestre-2010\/"},"modified":"2010-04-30T09:00:00","modified_gmt":"2010-04-30T07:00:00","slug":"gsk-18-nel-1-trimestre-2010","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/gsk-18-nel-1-trimestre-2010\/","title":{"rendered":"Gsk:, +18% in Q1 2010,"},"content":{"rendered":"

<\/font><\/p>\n

\"\" <\/font>In Q1 2010, GlaxoSmithKline's net profit rose 18% to \u00a31.34bn (\u20ac1.5bn) thanks largely to flu vaccine sales which reached \u00a3698m. Earnings per share were 30.7 pence, compared with 26.3 pence in Q1 2009. Sales rose 9% to \u00a37.4bn, driven by Asia Pacific (+45% ) of emerging markets (+43%) and Europe (+16%). Sales in the US market were down by 1% due to competition from generic drugs.<\/font><\/p>\n

( The Financial Times online \u2013 29\/04\/2010 , The Wall Street Journal Europe Pag.24 \u2013 29\/04\/2010 , The Financial Times Pag.34 \u2013 29\/04\/2010 , International Herald Tribune Pag.18 \u2013 29\/04 \/2010 , Les Echos online \u2013 29\/04\/2010 , Finance & Markets Pag.9 \u2013 29\/04\/2010 ) \"\"<\/em><\/font><\/font><\/span><\/p>\n

______________________________________________________________________________________________<\/font><\/span><\/p>\n

Verona. <\/strong>New appeal from Glaxosmtihkline workers to save the Verona research center of the pharmaceutical multinational, which announced its closure in recent months. The provincial councilors of the Democratic Party denounced that "the situation is very negative: in addition to the 518 researchers involved in the disposal, GSK has identified 18 redundancies out of 100 workers in the financial management and the cut of 200 of the 970 medical-scientific informants is also expected". "In total - said the leader of the Democratic Party, Vincenzo D'Arienzo - there are 736 jobs at risk".<\/font><\/font><\/p>\n

(Excerpt from "L'Arena di Verona" of 29 April 2010)<\/em><\/font><\/p>\n

<\/font><\/p>","protected":false},"excerpt":{"rendered":"

 Nel 1° trimestre 2010 l’utile netto di GlaxoSmithKline è salito del 18% a 1,34 mld di sterline (1,5 mld di euro) grazie soprattutto alle vendite dei vaccini antinfluenzali che hanno raggiunto 698 mln di sterline. Gli utili per azione si sono attestati a 30,7 pence, rispetto ai 26,3 del 1° trimestre 2009. Le vendite sono …<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-13079","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/13079","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=13079"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/13079\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=13079"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=13079"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=13079"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}